Buprenorphine Hydrochloride Injection
Product Images NDC 42023-179

2 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 42023-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 1)

Chemical Structure (Buprenorphine 1)
Chemical structure diagram of Buprenorphine Hydrochloride, showing its molecular framework with labeled groups including hydroxyl, methoxy, and cyclopropyl components.*
FDA Label Image

Principal Display Panel (0.3 mg/mL Vial Carton)

Principal Display Panel (0.3 mg/mL Vial Carton)
Box packaging label for Buprenorphine Hydrochloride Injection 0.3 mg/mL by Par Health USA, LLC. The label states the drug is for intramuscular or intravenous use and comes in a carton containing 5 single-dose 1 mL vials. The label includes dosage information, storage instructions, and the NDC 42023-179-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.